U.S. FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut Allergy by mparnell | Mar 18, 2019 | Portfolio News
Restoration Robotics and Venus Concept Announce Merger to Create a Leading Global Medical Aesthetics Company by mparnell | Mar 15, 2019 | Portfolio News
Aptinyx to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 21, 2019 by mparnell | Mar 14, 2019 | Portfolio News
Nabriva Therapeutics Reports 2018 Financial Results and Recent Corporate Highlights by mparnell | Mar 12, 2019 | Portfolio News
Akebia Therapeutics Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Vadadustat in Japanese Patients with Anemia Due to Chronic Kidney Disease by mparnell | Mar 12, 2019 | Portfolio News